COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05539664


Column Value
Trial registration number NCT05539664
Full text link
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

None

Contact
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

None

Registration date
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

2022-09-14

Recruitment status
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Not recruiting

Study design
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

inclusion criteria: male and female subjects aged between 18 and 80 years old (inclusive). diagnosed as general type of covid-19 according to the criteria of scheme for diagnosis and treatment of 2019 novel coronavirus pneumonia (trial version 9). subjects who are willing to participate and provided written informed consent form.

Exclusion criteria
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

diagnosed as mild, severe, critical or asymptomatic type of covid-19. subjects in the treatment or active stage of malignant tumor. subjects who are intolerable to inhalation treatment. subjects with mental disorders or cognitive impairment who are unable to provide consent. subjects with any immunodeficiency requiring chronic treatment with any corticosteroid or other immunosuppressants. complicate serious primary diseases such as heart, liver, kidney, and hematopoietic diseases; acute exacerbation phase of chronic obstructive pulmonary disease, or acute attack of bronchial asthma. subjects who are using any non-expectorant antioxidant drug, including large doses of vitamin c and vitamin e. subjects who are participating any other clinical study of any investigational drug or medical device. pregnant or lactating women. any other condition judged as inappropriate to participate in this study by the investigator.

Number of arms
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Ruijin Hospital

Inclusion age min
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

80

Countries
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

China

Type of patients
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Moderate disease at enrollment

Severity scale
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

3: Moderate disease at enrollment

Total sample size
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

188

primary outcome
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Time to negative viral nucleic acid detection from the start of the study treatment.

Notes
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 605, "treatment_name": "Hydrogen-oxygen nebulizer", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]